Target intelligence / Profile preview

Transcription initiation factor IA (TIF-IA)

Target
TIF-IA
Molecular classification
Transcription factor, RNA polymerase I-associated protein
01

Overview

Transcription initiation factor IA (TIF‐IA) is an essential transcription factor that regulates the synthesis of ribosomal RNA (rRNA) by facilitating the recruitment of RNA polymerase I to ribosomal DNA promoters. It acts as a key mediator between cellular growth signals—particularly those from the PI3K/Akt/mTOR pathway—and rRNA production. Phosphorylation events modulate its activity; for example, Akt activation enhances TIF‐IA stability and nucleolar localization via casein kinase 2–mediated phosphorylation, thereby promoting rRNA transcription and supporting cell proliferation. Conversely, downregulation or inhibition of TIF‐IA leads to reduced rRNA synthesis, impaired ribosome biogenesis, developmental arrest in model organisms like Drosophila, and decreased cell viability. Due to its central role in controlling protein biosynthesis capacity through ribosome production—and thus influencing cancer cell growth—TIF‐IA is considered a potential therapeutic target in oncology research.

Other names
Rrn3 (yeast homolog)TIF-IATranscription initiation factor IRNA polymerase I transcription factor TIF-IA
02

Mechanism of action

Inhibition of upstream signaling pathways (PI3K/Akt/mTOR) reduces TIF‐IA activity and rRNA synthesis

03

Biological functions

Ribosomal RNA synthesisCell growth regulationCell proliferation
04

Disease associations

Cancer (due to its role in cell proliferation and transformation)
05

Safety considerations

Potential for impaired cell growth or viability if excessively inhibited, as rRNA synthesis is essential for normal cellular function and organismal development
06

Interacting drugs

PI3K/mTOR inhibitors (e.g., LY294002)

Beyond the preview

Go deeper on Transcription initiation factor IA (TIF-IA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcription initiation factor IA (TIF-IA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call